Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 3/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 4/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3516667 | 0.84 | CA1 (0.46) | CA12CA1CA2CA7CA9 | |
| SCHEMBL30777888 | 0.84 | CA1 (0.46) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1134723 | 0.80 | CA1 (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL30250475 | 0.80 | CA1 (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL30548757 | 0.78 | CA1 (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL4992020 | 0.78 | CA1 (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL23887132 | 0.78 | SMN1; SMN2 (0.35) | ACHEBACE1ALDH1A1MAPTMEN1 | |
| SCHEMBL29792960 | 0.78 | ALDH1A1 (0.41) | CA12CA1CA2CA7CA9 | |
| SCHEMBL30176397 | 0.78 | SMN1; SMN2 (0.35) | ACHEBACE1ALDH1A1MAPTMEN1 | |
| SCHEMBL6322208 | 0.77 | NQO1 (0.50) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015335-A1 | AMINE-SUBSTITUTED FLUORESCENT COMPOUNDS | HUGHES HOWARD MED INST (US) | 2026-01-15 | — | — | US | disclosed |
| US-20260001857-A1 | FLUORINATED FLUORESCENT COMPOUNDS | HUGHES HOWARD MED INST (US) | 2026-01-01 | — | — | US | disclosed |
| US-20250282744-A1 | RED-SHIFTED FLUOROPHORES | HOWARD HUGHES MEDICAL INSTITUTE | 2025-09-11 | — | — | US | disclosed |
| US-12344594-B2 | Red-shifted fluorophores | HOWARD HUGHES MEDICAL INSTITUTE (US) | 2025-07-01 | — | — | US | disclosed |
| CN-119909072-A | Use of benzofuro [3,2-c ] quinolinone compounds for preventing and treating steatohepatitis related to metabolic dysfunction | 中国人民解放军空军军医大学 | 2025-05-02 | — | — | CN | disclosed |
| US-20250026721-A1 | COMPOUNDS AND METHODS FOR MODULATING RAS-PI3K | VIVIDION THERAPEUTICS, INC. | 2025-01-23 | — | — | US | disclosed |
| CN-118619932-A | GPR40 agonist and preparation method and application thereof | 广东众生睿创生物科技有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-116478183-A | Difunctional, reversible, quantitative and Golgi targeted fluorescent probe for monitoring intracellular redox steady state dynamics in real time | 中南大学 | 2023-07-25 | — | — | CN | disclosed |
| US-20230219988-A1 | ORGANOMETALLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-13 | — | — | US | disclosed |
| US-20230219988-A1 | ORGANOMETALLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-13 | — | — | US | disclosed |
| US-20100184800-A1 | Compounds for the Treatment of Hepatitis C | BRISTOL-MYERS SQUIBB COMPANY | 2010-07-22 | — | — | US | disclosed |
| WO-2010030538-A2 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-03-18 | — | — | WO | disclosed |
| US-20100063068-A1 | Compounds for the Treatment of Hepatitis C | BRISTOL-MYERS SQUIBB COMPANY | 2010-03-11 | — | — | US | disclosed |
| US-20100063068-A1 | Compounds for the Treatment of Hepatitis C | BRISTOL-MYERS SQUIBB COMPANY | 2010-03-11 | — | — | US | disclosed |
| EP-2069324-A1 | FUSED AMINO PYRIDINE AS HSP90 INHIBITORS | Curis, Inc. (US) | 2009-06-17 | — | — | EP | disclosed |
| WO-2008115719-A1 | FUSED AMINO PYRIDINE AS HSP90 INHIBITORS | CURIS, INC. (US) | 2008-09-25 | — | — | WO | disclosed |
| US-20080234314-A1 | FUSED AMINO PYRIDINE AS HSP90 INHIBITORS | CURIS, INC. | 2008-09-25 | — | — | US | disclosed |
| EP-1778632-B1 | INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION | BIOLIPOX AB (SE) | 2008-08-20 | — | — | EP | disclosed |
| EP-0049913-A2 | New ethenylimidazole derivatives, processes for their preparation and pharmaceutical compositions containing them; intermediates, useful in their preparation and a process for the preparation thereof | GIST-BROCADES N.V. (NL) | 1982-04-21 | — | — | EP | disclosed |
| US-4064139-A | TRANQUILIZERS, ANTICONVULSANTS, MUSCLE RELAXANTS, ANTI-PARKINSON'S DISEASE | MERCK & CO., INC. (US) | 1977-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12344594-B2 | Red-shifted fluorophores | TFEB, DDX21, CDC73 | CA12 3224/4885CA1 3712/4885CA2 3602/4885 |
| US-20250026721-A1 | COMPOUNDS AND METHODS FOR MODULATING RAS-PI3K | KRAS, HRAS, NRAS | CA12 4224/4885CA1 4347/4885CA2 3649/4885 |
| US-20250282744-A1 | RED-SHIFTED FLUOROPHORES | TFEB, DDX21, CDC73 | CA12 3226/4885CA1 3719/4885CA2 3606/4885 |
| US-20260001857-A1 | FLUORINATED FLUORESCENT COMPOUNDS | MSN, CHN2, EFHD2 | CA12 1656/4885CA1 2272/4885CA2 1664/4885 |
| US-20260015335-A1 | AMINE-SUBSTITUTED FLUORESCENT COMPOUNDS | AOC2, H1-2, CHAT | CA12 1648/4885CA1 2318/4885CA2 1614/4885 |
| US-20100063068-A1 | Compounds for the Treatment of Hepatitis C | HAVCR2, HCCS, SLC10A1 | CA12 1432/4885CA1 4156/4885CA2 4160/4885 |
| US-20100184800-A1 | Compounds for the Treatment of Hepatitis C | HAVCR2, HCCS, SLC10A1 | CA12 1432/4885CA1 4156/4885CA2 4160/4885 |
| US-20230219988-A1 | ORGANOMETALLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | LAGE3, GPX1, CRY1 | CA12 2081/4885CA1 2152/4885CA2 3385/4885 |
| US-20080234314-A1 | FUSED AMINO PYRIDINE AS HSP90 INHIBITORS | HSP90B1, HSP90AB1, HSP90AB2P | CA12 4717/4885CA1 3664/4885CA2 4250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.